Trastuzumab deruxtecan (solution), CAS [[1826843-81-5]]

Produktübersicht

• Artikelname: Trastuzumab deruxtecan (solution), CAS [[1826843-81-5]]
• Artikelnummer: MCE-HY-138298
• Hersteller Artikelnummer: HY-138298
• Alternativnummer: MCE-HY-138298-1MG,MCE-HY-138298-5MG,MCE-HY-138298-10MG,MCE-HY-138298-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: DS-8201 (solution), DS-8201a (solution)

Produktbeschreibung

Trastuzumab deruxtecan (T-DXd, DS-8201a) (solution) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer[1][2].

Produkteigenschaften

• Molekulargewicht: 153000 (average)
• Reinheit: 99.64
• CAS Nummer: [1826843-81-5]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs),EGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: ADC Related